GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avax Technologies Inc (OTCPK:AVXT) » Definitions » EV-to-EBIT

Avax Technologies (Avax Technologies) EV-to-EBIT : 0.00 (As of Jun. 15, 2024)


View and export this data going back to . Start your Free Trial

What is Avax Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Avax Technologies's Enterprise Value is $0.00 Mil. Avax Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2008 was $-7.52 Mil. Therefore, Avax Technologies's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Avax Technologies's EV-to-EBIT or its related term are showing as below:

AVXT's EV-to-EBIT is not ranked *
in the Biotechnology industry.
Industry Median: 9.705
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Avax Technologies's Enterprise Value for the quarter that ended in Sep. 2008 was $6.79 Mil. Avax Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2008 was $-7.52 Mil. Avax Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2008 was -110.75%.


Avax Technologies EV-to-EBIT Historical Data

The historical data trend for Avax Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avax Technologies EV-to-EBIT Chart

Avax Technologies Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.93 -2.99 -2.63 -3.17 -1.25

Avax Technologies Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Avax Technologies's EV-to-EBIT

For the Biotechnology subindustry, Avax Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avax Technologies's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avax Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Avax Technologies's EV-to-EBIT falls into.



Avax Technologies EV-to-EBIT Calculation

Avax Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-7.515
=0.00

Avax Technologies's current Enterprise Value is $0.00 Mil.
Avax Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avax Technologies  (OTCPK:AVXT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Avax Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2008 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2008 ) =EBIT / Enterprise Value (Q: Sep. 2008 )
=-7.515/6.7853
=-110.75 %

Avax Technologies's Enterprise Value for the quarter that ended in Sep. 2008 was $6.79 Mil.
Avax Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avax Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Avax Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Avax Technologies (Avax Technologies) Business Description

Traded in Other Exchanges
N/A
Address
9200 Indian Creek Parkway, Suite 200, Overland Park, KS, USA, 66210
Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It also involved in the development and commercial readiness in the immuno-oncology arena.
Executives
Carl Spana director PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512
Prendergast John K A director ROBERTS SHERIDAN & KOTEL, 12 EAST 49TH STREET 30TH FL, NEW YORK NY 10017

Avax Technologies (Avax Technologies) Headlines

No Headlines